Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

White House, Allergan Spar Over 'Un-American' Claim

This article was originally published in Scrip

Executive Summary

The White House on April 6 fought back against accusations from Allergan PLC CEO Brent Saunders the Obama administration's move to institute new rules aimed at thwarting corporate inversion was "un-American" and had specifically been constructed to take down the company's $160bn merger deal with Pfizer Inc., which had, indeed, fallen apart in light of the US Treasury Department's actions.

Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

SC064912

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel